C13H14N2O6
Neat
294.26
+5°C
Room Temperature
1246616-73-8; DS7HC3Z5YA; (4R, 12aS)-3, 4, 6, 8, 12, 12a-Hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-2H-pyrido(1', 2':4, 5)pyrazino(2, 1-b)(1, 3)oxazine-9-carboxylic acid; (4R, 12aS)-3, 4, 6, 8, 12, 12a-Hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic acid; RefChem:1050502; (4R, 12aS)-7-Hydroxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic acid; (4R, 12aS)-7-hydroxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-[1, 3]oxazino[3, 2-d]pyrido[1, 2-a]pyrazine-9-carboxylic acid; Dolutegravir impurity F; Dolutegravir Impurity 62; Dolutegravir Impurity N13; SCHEMBL81652; F11520; (3S, 7R)-11-Hydroxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10, 13-diene-13-carboxylic acid; (4R, 12aS)-7-Hydroxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylicacid; 2H-Pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic acid, 3, 4, 6, 8, 12, 12a-hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-, (4R and 12aS)-
(3S, 7R)-11-hydroxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10 and 13-diene-13-carboxylic acid
InChI=1S/C13H14N2O6/c1-6-2-3-21-8-5-14-4-7(13(19)20)10(16)11(17)9(14)12(18)15(6)8/h4,6,8,17H,2-3,5H2,1H3,(H,19,20)/t6-,8+/m1/s1